Breaking News Instant updates and real-time market news.

SQZ

SQZ Biotechnologies

$27.48 /

-4.56 (-14.23%)

06:57
11/24/20
11/24
06:57
11/24/20
06:57

SQZ Biotechnologies initiated with a Buy at Stifel

Stifel analyst Stephen Willey initiated coverage of SQZ Biotechnologies with a Buy rating and $38 price target. He sees the company's "Cell Squeeze" technology platform as a significant advancement in next-generation cell therapies and believes Phase 1 data for SQZ-PMBC-HPV in HPV+ solid tumors has broader de-risking implications for the platform across a broad spectrum of potential targets and non-oncology diseases, Willey tells investors. He also believes the novelty of the company's technology and diversity of its applications warrants a premium to current valuation, Willey added.

  • 30

    Oct

SQZ SQZ Biotechnologies
$27.48 /

-4.56 (-14.23%)

11/24/20 BofA
SQZ Biotechnologies initiated with a Buy at BofA
11/24/20 BofA
SQZ Biotechnologies initiated with a Buy at BofA
11/24/20 BTIG
SQZ Biotechnologies initiated with a Buy at BTIG

TODAY'S FREE FLY STORIES

Recommendations
Cimarex Energy price target raised to $61 from $48 at Cowen » 07:46
01/19/21
01/19
07:46
01/19/21
07:46
XEC

Cimarex Energy

$47.56 /

-1.96 (-3.96%)

Cowen analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XEC Cimarex Energy
$47.56 /

-1.96 (-3.96%)

XEC Cimarex Energy
$47.56 /

-1.96 (-3.96%)

01/14/21 Barclays
Cimarex Energy price target raised to $55 from $48 at Barclays
01/13/21 JPMorgan
JPMorgan announces top 10 energy picks for 2021
01/11/21 Mizuho
Cimarex Energy price target raised to $62 from $43 at Mizuho
12/15/20 Goldman Sachs
Cimarex Energy upgraded to Buy from Neutral at Goldman Sachs
XEC Cimarex Energy
$47.56 /

-1.96 (-3.96%)

XEC Cimarex Energy
$47.56 /

-1.96 (-3.96%)

Hot Stocks
Thryv Holdings announces integration with Gmail » 07:46
01/19/21
01/19
07:46
01/19/21
07:46
THRY

Thryv Holdings

$18.85 /

-0.71 (-3.63%)

Thryv Holdings announces…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
THRY Thryv Holdings
$18.85 /

-0.71 (-3.63%)

THRY Thryv Holdings
$18.85 /

-0.71 (-3.63%)

11/17/20 William Blair
Thryv Holdings initiated with an Outperform at William Blair
Recommendations
Cryoport price target raised to $75 from $54 at KeyBanc » 07:45
01/19/21
01/19
07:45
01/19/21
07:45
CYRX

Cryoport

$63.99 /

-3.36 (-4.99%)

KeyBanc analyst Paul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CYRX Cryoport
$63.99 /

-3.36 (-4.99%)

CYRX Cryoport
$63.99 /

-3.36 (-4.99%)

01/14/21 Roth Capital
Cryoport price target raised to $72 from $60 at Roth Capital
01/12/21 B. Riley Securities
Cryoport price target raised to $69 from $66 at B. Riley Securities
11/09/20 KeyBanc
Cryoport initiated with an Overweight at KeyBanc
10/13/20 Credit Suisse
Chart Industries price target raised to $80 from $72 at Credit Suisse
CYRX Cryoport
$63.99 /

-3.36 (-4.99%)

CYRX Cryoport
$63.99 /

-3.36 (-4.99%)

CYRX Cryoport
$63.99 /

-3.36 (-4.99%)

Downgrade
Genmab downgraded to Equal Weight on valuation at Morgan Stanley » 07:44
01/19/21
01/19
07:44
01/19/21
07:44
GMAB

Genmab

$33.00 /

+12 (+1.00%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GMAB Genmab
$33.00 /

+12 (+1.00%)

GMAB Genmab
$33.00 /

+12 (+1.00%)

06:01 Today Morgan Stanley
Genmab downgraded to Equal Weight from Overweight at Morgan Stanley
01/15/21 H.C. Wainwright
Genmab price target raised to $49 from $44 at H.C. Wainwright
01/04/21 RBC Capital
Genmab price target raised to $46 from $40 at RBC Capital
11/16/20 UBS
Genmab price target raised to DKK 2,680 from DKK 2,540 at UBS
Recommendations
PDC Energy price target raised to $33 from $27 at Cowen » 07:44
01/19/21
01/19
07:44
01/19/21
07:44
PDCE

PDC Energy

$24.20 /

-1.48 (-5.76%)

Cowen analyst Gabe Daoud…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PDCE PDC Energy
$24.20 /

-1.48 (-5.76%)

PDCE PDC Energy
$24.20 /

-1.48 (-5.76%)

01/13/21 JPMorgan
JPMorgan announces top 10 energy picks for 2021
01/13/21 Wells Fargo
PDC Energy price target raised to $33 from $28 at Wells Fargo
12/29/20 Truist
PDC Energy price target raised to $27 from $17 at Truist
12/16/20 JPMorgan
PDC Energy price target raised to $26 from $24 at JPMorgan
PDCE PDC Energy
$24.20 /

-1.48 (-5.76%)

Earnings
State Street reports Q4 EPS $1.39, consensus $1.56 » 07:44
01/19/21
01/19
07:44
01/19/21
07:44
STT

State Street

$77.30 /

-2.27 (-2.85%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
STT State Street
$77.30 /

-2.27 (-2.85%)

STT State Street
$77.30 /

-2.27 (-2.85%)

01/11/21 Piper Sandler
State Street price target raised to $81 from $69 at Piper Sandler
01/05/21 Wolfe Research
State Street downgraded to Underperform from Peer Perform at Wolfe Research
01/05/21 Goldman Sachs
State Street downgraded to Neutral from Buy at Goldman Sachs
01/05/21 Goldman Sachs
Northern Trust downgraded to Sell from Neutral at Goldman Sachs
STT State Street
$77.30 /

-2.27 (-2.85%)

STT State Street
$77.30 /

-2.27 (-2.85%)

STT State Street
$77.30 /

-2.27 (-2.85%)

Earnings
AirBoss of America sees 2020 revenue $498M-$503M » 07:44
01/19/21
01/19
07:44
01/19/21
07:44
ABSSF

AirBoss of America

$0.00 /

+ (+0.00%)

"2020 was another…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ABSSF AirBoss of America
$0.00 /

+ (+0.00%)

ABSSF AirBoss of America
$0.00 /

+ (+0.00%)

01/14/21 Canaccord
AirBoss of America price target lowered to C$27 from C$43 at Canaccord
12/18/20 TD Securities
AirBoss of America price target lowered to C$29 from C$32 at TD Securities
11/12/20 Stifel
AirBoss of America price target lowered to C$33 from C$34 at Stifel
11/12/20 TD Securities
AirBoss of America price target raised to C$32 from C$31 at TD Securities
Recommendations
Avantor price target raised to $40 from $33 at KeyBanc » 07:43
01/19/21
01/19
07:43
01/19/21
07:43
AVTR

Avantor

$28.96 /

+0.24 (+0.84%)

KeyBanc analyst Paul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AVTR Avantor
$28.96 /

+0.24 (+0.84%)

AVTR Avantor
$28.96 /

+0.24 (+0.84%)

01/06/21 Cowen
Avantor named a top diversified pick at Cowen
12/16/20 Citi
Avantor price target raised to $33 from $28 at Citi
11/10/20 KeyBanc
Avantor assumed with an Overweight from Sector Weight at KeyBanc
10/30/20 Citi
Avantor price target raised to $28 from $24 at Citi
AVTR Avantor
$28.96 /

+0.24 (+0.84%)

  • 06
    Nov
  • 20
    Aug
  • 21
    May
AVTR Avantor
$28.96 /

+0.24 (+0.84%)

Downgrade
Cowen downgrades Total to Market Perform, In line performance seen » 07:43
01/19/21
01/19
07:43
01/19/21
07:43
TOT

Total

$44.26 /

-1.71 (-3.72%)

As reported previously,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
TOT Total
$44.26 /

-1.71 (-3.72%)

TOT Total
$44.26 /

-1.71 (-3.72%)

06:41 Today Cowen
Total downgraded to Market Perform from Outperform at Cowen
01/15/21 JPMorgan
Total price target raised to EUR 46 from EUR 44 at JPMorgan
01/14/21 Societe Generale
Societe Generale downgrades three EU oil & gas names after strong performances
01/13/21 Credit Suisse
Total price target raised to EUR 41.50 from EUR 39 at Credit Suisse
TOT Total
$44.26 /

-1.71 (-3.72%)

Downgrade
Take-Two downgraded to Neutral from Buy at UBS » 07:42
01/19/21
01/19
07:42
01/19/21
07:42
TTWO

Take-Two

$196.32 /

+0.87 (+0.45%)

UBS analyst Eric Sheridan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TTWO Take-Two
$196.32 /

+0.87 (+0.45%)

TTWO Take-Two
$196.32 /

+0.87 (+0.45%)

01/14/21 MKM Partners
Take-Two downgraded to Neutral from Buy at MKM Partners
01/14/21 Deutsche Bank
Take-Two price target raised to $240 from $200 at Deutsche Bank
01/13/21
Fly Intel: Top five analyst downgrades
01/13/21 KeyBanc
Take-Two downgraded to Sector Weight on FY22 slate questions at KeyBanc
TTWO Take-Two
$196.32 /

+0.87 (+0.45%)

TTWO Take-Two
$196.32 /

+0.87 (+0.45%)

TTWO Take-Two
$196.32 /

+0.87 (+0.45%)

TTWO Take-Two
$196.32 /

+0.87 (+0.45%)

Syndicate
Athira Pharma files to sell 4M shares of common stock » 07:41
01/19/21
01/19
07:41
01/19/21
07:41
ATHA

Athira Pharma

$26.47 /

-0.43 (-1.60%)

Goldman, Jefferies and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATHA Athira Pharma
$26.47 /

-0.43 (-1.60%)

ATHA Athira Pharma
$26.47 /

-0.43 (-1.60%)

10/13/20 Jefferies
Athira Pharma initiated with a Buy at Jefferies
10/13/20 JMP Securities
Athira Pharma initiated with an Outperform at JMP Securities
10/13/20 Stifel
Athira Pharma initiated with a Buy at Stifel
10/13/20 Goldman Sachs
Athira Pharma initiated with a Buy at Goldman Sachs
ATHA Athira Pharma
$26.47 /

-0.43 (-1.60%)

  • 18
    Sep
Downgrade
Editas Medicine downgraded to Underweight from Equal Weight at Morgan Stanley » 07:41
01/19/21
01/19
07:41
01/19/21
07:41
EDIT

Editas Medicine

$76.07 /

+0.19 (+0.25%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EDIT Editas Medicine
$76.07 /

+0.19 (+0.25%)

EDIT Editas Medicine
$76.07 /

+0.19 (+0.25%)

01/13/21 Wells Fargo
Editas Medicine price target raised to $86 from $69 at Wells Fargo
01/08/21 Raymond James
Editas downgraded to Market Perform at Raymond James (Thursday morning)
01/07/21 Raymond James
Editas Medicine downgraded to Market Perform from Outperform at Raymond James
12/10/20
Fly Intel: Top five analyst upgrades
EDIT Editas Medicine
$76.07 /

+0.19 (+0.25%)

  • 24
    Jun
EDIT Editas Medicine
$76.07 /

+0.19 (+0.25%)

EDIT Editas Medicine
$76.07 /

+0.19 (+0.25%)

EDIT Editas Medicine
$76.07 /

+0.19 (+0.25%)

Hot Stocks
CorVel, ReedGroup partner to offer integrated disability management » 07:41
01/19/21
01/19
07:41
01/19/21
07:41
CRVL

CorVel

$105.12 /

-0.41 (-0.39%)

The companies said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CRVL CorVel
$105.12 /

-0.41 (-0.39%)

Hot Stocks
Frequency Therapeutics appoints Quentin McCubbin as chief manufacturing officer » 07:40
01/19/21
01/19
07:40
01/19/21
07:40
FREQ

FREQ

/

+

, CERE

Cerevel Therapeutics

$14.46 /

-0.59 (-3.92%)

Frequency Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FREQ FREQ
/

+

CERE Cerevel Therapeutics
$14.46 /

-0.59 (-3.92%)

FREQ FREQ
/

+

12/22/20 B. Riley Securities
Frequency Therapeutics initiated with a Buy at B. Riley Securities
12/16/20 Oppenheimer
Frequency Therapeutics price target raised to $48 from $36 at Oppenheimer
07/13/20 Oppenheimer
Frequency Therapeutics initiated with an Outperform at Oppenheimer
05/18/20 JPMorgan
JPMorgan downgrades Frequency Therapeutics on unclear data timelines
CERE Cerevel Therapeutics
$14.46 /

-0.59 (-3.92%)

12/10/20 Goldman Sachs
Cerevel Therapeutics initiated with a Buy at Goldman Sachs
11/23/20 Jefferies
Cerevel Therapeutics initiated with a Buy at Jefferies
11/09/20
Fly Intel: Top five analyst initiations
11/09/20 Stifel
Cerevel Therapeutics initiated with a Buy at Stifel
FREQ FREQ
/

+

Downgrade
Peloton downgraded to Sell from Neutral at UBS » 07:40
01/19/21
01/19
07:40
01/19/21
07:40
PTON

Peloton

/

+

UBS analyst Eric Sheridan…

UBS analyst Eric Sheridan downgraded Peloton Interactive to Sell from Neutral with a price target of $124, up from $115. The stock is "emblematic of a market that values growth over any semblance of valuation that can be justified" on a multiple year view based on fundamentals, Sheridan tells investors in a research note. The analyst thinks investors "need to be wary of the rising trend of bull market optimism" in a handful of businesses that have been either COVID-19 "beneficiaries" or have come to the public markets over the last 18 months. He sees a negative risk/reward skew for Peloton shares at current levels.

ShowHide Related Items >><<
PTON Peloton
/

+

PTON Peloton
/

+

01/08/21
Fly Intel: Top five analyst initiations
01/08/21 Gordon Haskett
Peloton initiated with a Buy at Gordon Haskett
01/05/21 Stifel
Stifel adds Vroom to Select List, removes Buy-rated Peloton
01/04/21 Barclays
Peloton assumed with an Overweight at Barclays
PTON Peloton
/

+

PTON Peloton
/

+

PTON Peloton
/

+

PTON Peloton
/

+

General news
Treasury Market Outlook: U.S. equity futures are reopening with a bullish tone » 07:40
01/19/21
01/19
07:40
01/19/21
07:40

Treasury Market Outlook:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Gilat Satellite awarded contracts for cellular backhaul projects in Mexico » 07:39
01/19/21
01/19
07:39
01/19/21
07:39
GILT

Gilat Satellite

$7.32 /

-0.17 (-2.27%)

Gilat Satellite Networks…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GILT Gilat Satellite
$7.32 /

-0.17 (-2.27%)

GILT Gilat Satellite
$7.32 /

-0.17 (-2.27%)

GILT Gilat Satellite
$7.32 /

-0.17 (-2.27%)

Downgrade
Fiverr downgraded to Sell from Neutral at UBS » 07:39
01/19/21
01/19
07:39
01/19/21
07:39
FVRR

Fiverr

$267.03 /

-3.195 (-1.18%)

UBS analyst Eric Sheridan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FVRR Fiverr
$267.03 /

-3.195 (-1.18%)

FVRR Fiverr
$267.03 /

-3.195 (-1.18%)

01/12/21 Citi
Fiverr price target raised to $270 from $185 at Citi
12/21/20 Goldman Sachs
Fiverr initiated with a Buy at Goldman Sachs
11/20/20 Needham
Fiverr price target raised to $210 from $180 at Needham
11/18/20 BTIG
Upwork price target raised to $42 from $27 at BTIG
FVRR Fiverr
$267.03 /

-3.195 (-1.18%)

  • 29
    May
FVRR Fiverr
$267.03 /

-3.195 (-1.18%)

FVRR Fiverr
$267.03 /

-3.195 (-1.18%)

Downgrade
Chewy downgraded to Sell from Neutral at UBS » 07:39
01/19/21
01/19
07:39
01/19/21
07:39
CHWY

Chewy

$108.05 /

-6.57 (-5.73%)

UBS analyst Eric Sheridan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
CHWY Chewy
$108.05 /

-6.57 (-5.73%)

CHWY Chewy
$108.05 /

-6.57 (-5.73%)

01/13/21 Credit Suisse
Chewy price target raised to $121 from $104 at Credit Suisse
01/04/21 Barclays
Chewy assumed with an Equal Weight at Barclays
12/18/20 William Blair
Chewy share growth should stabilize at 20%-25%, says William Blair
12/17/20 Needham
Chewy price target raised to $110 from $90 at Needham
CHWY Chewy
$108.05 /

-6.57 (-5.73%)

  • 17
    Sep
CHWY Chewy
$108.05 /

-6.57 (-5.73%)

CHWY Chewy
$108.05 /

-6.57 (-5.73%)

CHWY Chewy
$108.05 /

-6.57 (-5.73%)

Hot Stocks
Brickell announces Japan Phase 3 study results for sofpironium bromide gel » 07:38
01/19/21
01/19
07:38
01/19/21
07:38
BBI

Brickell Biotech

$1.10 /

+0.03 (+2.80%)

Brickell Biotech…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BBI Brickell Biotech
$1.10 /

+0.03 (+2.80%)

BBI Brickell Biotech
$1.10 /

+0.03 (+2.80%)

09/25/20 Lake Street
Approval in Japan validating for Brickell Biotech, says Lake Street
08/28/20 Lake Street
Brickell Biotech initiated with a Buy at Lake Street
08/25/20 Oppenheimer
Brickell Biotech initiated with an Outperform at Oppenheimer
  • 23
    Oct
  • 18
    Jun
Hot Stocks
Heat Biologics commences manufacturing process for ZVX-60 » 07:37
01/19/21
01/19
07:37
01/19/21
07:37
HTBX

Heat Biologics

$6.36 /

+0.15 (+2.42%)

Heat Biologics announces…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HTBX Heat Biologics
$6.36 /

+0.15 (+2.42%)

HTBX Heat Biologics
$6.36 /

+0.15 (+2.42%)

12/24/20 B. Riley Securities
Heat Biologics transferred with a Buy at B. Riley Securities
10/14/20
Fly Intel: Top five analyst initiations
10/14/20 B. Riley Securities
B. Riley sees 200% upside in 'value vaccine play' Heat Biologics
10/14/20 B. Riley Securities
Heat Biologics initiated with a Buy at B. Riley Securities
HTBX Heat Biologics
$6.36 /

+0.15 (+2.42%)

HTBX Heat Biologics
$6.36 /

+0.15 (+2.42%)

Hot Stocks
Ashland to acquire personal care business from Schulke & Mayr for EUR262.5M » 07:37
01/19/21
01/19
07:37
01/19/21
07:37
ASH

Ashland

$84.99 /

-1.33 (-1.54%)

, EQT

EQT Corporation

$18.50 /

+0.59 (+3.29%)

Ashland Global Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ASH Ashland
$84.99 /

-1.33 (-1.54%)

EQT EQT Corporation
$18.50 /

+0.59 (+3.29%)

ASH Ashland
$84.99 /

-1.33 (-1.54%)

07:18 Today Deutsche Bank
Ashland named 'Catalyst Call: Buy Idea' at Deutsche Bank
10/09/20 Deutsche Bank
Deutsche initiates 'Buy Catalyst Call' on Ashland ahead of results
09/22/20 Evercore ISI
Ashland initiated with an In Line at Evercore ISI
08/24/20 JPMorgan
Ashland price target raised to $75 from $62 at JPMorgan
EQT EQT Corporation
$18.50 /

+0.59 (+3.29%)

01/11/21 Mizuho
EQT Corporation price target lowered to $19 from $28 at Mizuho
12/15/20
Fly Intel: Top five analyst initiations
12/15/20 BofA
EQT Corporation initiated with a Buy at BofA
12/08/20 JPMorgan
EQT Corporation downgraded to Neutral with $17 target at JPMorgan
ASH Ashland
$84.99 /

-1.33 (-1.54%)

EQT EQT Corporation
$18.50 /

+0.59 (+3.29%)

  • 17
    Nov
  • 28
    Oct
EQT EQT Corporation
$18.50 /

+0.59 (+3.29%)

EQT EQT Corporation
$18.50 /

+0.59 (+3.29%)

Upgrade
Morgan Stanley upgrades Gilead to Overweight at start of 'pivotal pipeline year' » 07:35
01/19/21
01/19
07:35
01/19/21
07:35
GILD

Gilead

$63.35 /

+0.95 (+1.52%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GILD Gilead
$63.35 /

+0.95 (+1.52%)

GILD Gilead
$63.35 /

+0.95 (+1.52%)

06:01 Today Morgan Stanley
Gilead upgraded to Overweight from Equal Weight at Morgan Stanley
01/11/21 Piper Sandler
Piper says hard for Gilead investors to ascribe long-term value to Veklury
01/04/21 Guggenheim
Gilead upgraded to Buy from Neutral at Guggenheim
12/22/20 Citi
Gilead price target lowered to $72 from $75 at Citi
GILD Gilead
$63.35 /

+0.95 (+1.52%)

GILD Gilead
$63.35 /

+0.95 (+1.52%)

GILD Gilead
$63.35 /

+0.95 (+1.52%)

GILD Gilead
$63.35 /

+0.95 (+1.52%)

Options
Unusual call flow in option market yesterday » 07:35
01/19/21
01/19
07:35
01/19/21
07:35
SLQT

SelectQuote

$23.55 /

+0.98 (+4.34%)

Notable call activity was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SLQT SelectQuote
$23.55 /

+0.98 (+4.34%)

SLQT SelectQuote
$23.55 /

+0.98 (+4.34%)

10/06/20 Credit Suisse
Walmart entry shows attractiveness of insurance market, says Credit Suisse
10/06/20 Citi
Walmart entry a 'significant competitive threat' to eHealth, says Citi
09/08/20 Credit Suisse
SelectQuote price target lowered to $31 from $38 at Credit Suisse
07/01/20 SVB Leerink
SVB Leerink bullish on Benefytt Technologies, initiates with an Outperform
SLQT SelectQuote
$23.55 /

+0.98 (+4.34%)

  • 21
    May
SLQT SelectQuote
$23.55 /

+0.98 (+4.34%)

SLQT SelectQuote
$23.55 /

+0.98 (+4.34%)

Recommendations
AMN Healthcare price target raised to $81 from $72 at BMO Capital » 07:34
01/19/21
01/19
07:34
01/19/21
07:34
AMN

AMN Healthcare

$72.10 /

+0.075 (+0.10%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
AMN AMN Healthcare
$72.10 /

+0.075 (+0.10%)

11/06/20 Truist
AMN Healthcare price target raised to $78 from $68 at Truist
11/06/20 Credit Suisse
AMN Healthcare price target raised to $76 from $63 at Credit Suisse
10/08/20 BofA
AMN Healthcare initiated with a Buy at BofA
08/07/20 BMO Capital
AMN Healthcare price target raised to $65 from $50 at BMO Capital
AMN AMN Healthcare
$72.10 /

+0.075 (+0.10%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.